These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2538099)

  • 1. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
    Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies.
    Jones EA; Yurdaydin C; Basile AS
    Alcohol Alcohol Suppl; 1993; 2():175-80. PubMed ID: 7748296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
    Ahboucha S; Pomier-Layrargues G; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):241-51. PubMed ID: 15554420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
    Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA
    J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
    Basile AS; Gammal SH; Mullen KD; Jones EA; Skolnick P
    J Neurosci; 1988 Jul; 8(7):2414-21. PubMed ID: 2854841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
    Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
    Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.
    Jones EA; Basile AS; Skolnick P
    Adv Exp Med Biol; 1990; 272():121-34. PubMed ID: 1966504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand.
    Basile AS; Gammal SH; Jones EA; Skolnick P
    J Neurochem; 1989 Oct; 53(4):1057-63. PubMed ID: 2549194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA; Schafer DF; Ferenci P; Pappas SC
    Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.
    Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P
    Adv Biochem Psychopharmacol; 1990; 46():189-200. PubMed ID: 1963266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):331-43. PubMed ID: 15554425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
    Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS
    J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
    Basile AS; Hughes RD; Harrison PM; Murata Y; Pannell L; Jones EA; Williams R; Skolnick P
    N Engl J Med; 1991 Aug; 325(7):473-8. PubMed ID: 1649403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of hepatic encephalopathy.
    Jones EA
    Clin Liver Dis; 2000 May; 4(2):467-85. PubMed ID: 11232201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.
    Schafer DF; Jones EA
    Lancet; 1982 Jan; 1(8262):18-20. PubMed ID: 6119414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.